532 related articles for article (PubMed ID: 25624724)
1. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.
Ding MX; Lin XQ; Fu XY; Zhang N; Li JC
World J Gastroenterol; 2006 Jul; 12(28):4582-5. PubMed ID: 16874878
[TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
[TBL] [Abstract][Full Text] [Related]
4. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.
Li SL; Gao DL; Zhao ZH; Liu ZW; Zhao QM; Yu JX; Chen KS; Zhang YH
World J Gastroenterol; 2007 Dec; 13(45):6076-81. PubMed ID: 18023103
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
7. Significance of the expression of integrin β1, VEGF and MVD in hypopharyngeal squamous cell carcinoma.
Hong YM; Gan WG; Xu ZH
Genet Mol Res; 2014 Aug; 13(3):6455-65. PubMed ID: 25158264
[TBL] [Abstract][Full Text] [Related]
8. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer.
Ming J; Liu N; Gu Y; Qiu X; Wang EH
Pathology; 2009 Feb; 41(2):118-26. PubMed ID: 19152186
[TBL] [Abstract][Full Text] [Related]
9. Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis.
Zhang HZ; Liu JG; Wei YP; Wu C; Cao YK; Wang M
World J Gastroenterol; 2007 Aug; 13(30):4126-30. PubMed ID: 17696235
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang.
Zhang L; Wang Y; Bai G; Zhang J; Yang M; Ma X
Tumour Biol; 2015 Dec; 36(12):9277-83. PubMed ID: 26099724
[TBL] [Abstract][Full Text] [Related]
11. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
12. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
13. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Kono T; Yazawa K; Igarashi J; Watanabe H; Nimura Y; Hanazaki K; Adachi W; Amano J
Hepatogastroenterology; 1999; 46(26):952-8. PubMed ID: 10370645
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
16. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue.
Eshghyar N; Mohammadi N; Rahrotaban S; Motahhary P; Vahedi Vaez SM
Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies.
Kleespies A; Bruns CJ; Jauch KW
Onkologie; 2005 May; 28(5):281-8. PubMed ID: 15867486
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of VEGF-C mRNA and CD 31 in esophageal squamous cell carcinoma].
Ding MX; Li JC
Shi Yan Sheng Wu Xue Bao; 2003 Aug; 36(4):269-74. PubMed ID: 14574989
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Sun ZG; Liu XY; Zhang M; Wang Z
Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
